ESHRE 40th Annual Meeting

Amsterdam. The Netherlands

7-10 July 2024

Appointments with our professionals

Optimising Reproductive Outcomes: The Science of Endometrial Well-being

Optimising Reproductive Outcomes:

The Science of Endometrial Well-being

We are excited to attend ESHRE 2024

Schedule meetings with us to learn about our latest service developments.

With a strong bet on innovation, research, and development, IGLS’s top-tier scientists and multidisciplinary teams pool the best of their expertise and know-how to deliver best-in-class, precise, and reliable solutions for assisted reproduction centres, hospitals, and healthcare institutions across the world.

We look forward to seeing you at ESHRE 2024 and sharing our latest innovations!

Appointments with our professionals

Reproductive health

The tests described below are especially useful in cases of implantation failures, recurrent abortions, patients with chronic endometritis and for in-vitro fertilisation treatments, as well as for any patient seeking a healthy pregnancy.

Endometrial receptivity study, to identify the window of implantation, the ideal moment for embryo transfer.

of woman dellivered a baby when perfoming the transfer in the implatation window

of woman delivered a baby when performing the transfer in the implantation window

MicroBioMap® es una prueba molecular que analiza en el endometrio la presencia de 18 microorganismos patógenos (hongos, bacterias y protozoos), definidos como involucrados en el desarrollo de la endometritis crónica y, además, detecta 4 especies de lactobacilos, descritas como beneficiosas para la salud reproductiva.

Comprehensive analysis of the endometrial environment.
Crucial information used by the doctor to determine the optimal treatment.

Detecting and treating<br />
endometrial pathogens<br />
increases the chances of<br />
pregnancy by

detecting and treating endometrial pathogens increases the chances of pregnancy by

Im Map® es nuestro test inmunológico específico dirigido a determinar las subpoblaciones inmunitarias presentes en el endometrio y a identificar alteraciones de éstas observadas en condiciones médicas asociadas a fallo de implantación o aborto espontáneo recurrente. La determinación de alteraciones permitirá establecer un tratamiento de inmunoterapia dirigido a restablecer el perfil inmunitario endometrial e incrementar la probabilidad de éxito en el embarazo.

Immune mapping detects and describes the maternal endometrial immune profile. The result helps the doctor to define the appropriate therapy.

Woman with recurrent<br />
implantation failures have<br />
dysregulated endometrial<br />
inmunology

woman with recurrent implantation failures have dysregulated endometrial immunology

Im Map® Immunology Map

Tests performed

Certified laboratory

Have You Heard of SpermXpression®?

The Male Infertility Test that Reveals What Conventional Semen Analysis Can’t Detect

What is SpermXpression®?
SpermXpression® is a molecular tool that determines whether a semen sample has a normal or altered PRM1/PRM2 protamine expression profile.
Advanced Diagnosis:
Identifies cases of male infertility that conventional techniques miss, improving outcomes in assisted reproduction treatments.
Impact on Semen Quality:
Patients with an abnormal PRM1/PRM2 ratio generally have lower semen quality, reduced fertilisation capacity, and lower pregnancy rates in IVF.
Clinical Benefits:
Enhances the diagnosis of infertile couples and aids in selecting the most appropriate therapeutic and treatment strategies, increasing pregnancy chances.
Analysis Process:
Uses high-performance quantitative PCR to analyse the expression of protamines in a semen sample, determining if the protein ratio affects male fertility.

IGLS Genetic and immunology testing laboratory With a strong bet on innovation, research & development, IGLS top-tier scientists and multidisciplinary teams, pool the best of their expertise and know-how to deliver best-in-class, precise and reliable solutions for assisted reproduction centres, hospitals and healthcare institutions across the world.

Preimplantation embryo development rates in cycles using ejaculated spermatozoa (EJACULATE cycle) and testicular sperm cells (TESA cycle). Significantly higher fertilization, blastocyst, and good-quality blastocyst rates were obtained in the TESA-cycle group compared with the EJACULATE-cycle group. Significant differences between EJACULATE-cycle and TESA-cycle groups are highlighted with an asterisk (*) with paired Student‘s t-test/a pound (#) with Wilcoxon signed-rank test, P< 0.05. Error bars represent the standard deviation.

Latest blogs

IGLS acredita sus servicios bajo la norma ISO 15189

IGLS Expands Its ISO 15189 Accredited Services

Moffet 2023 - Local immune recognition of trophoblast in early human pregnancy controversies and questions

The Role of the Endometrial Immune profile in Fertility Success: Insights from the Im Map® Test

Recent controversies have cast doubt on the credibility of endometrial receptivity essays, which play a pivotal role in the successful embryonic implantation. The human endometrium is an amazing structure that goes through changes during the menstrual cycle to create a receptive state for the embryo. This special period, known as the window of implantation (WOI), is when the endometrium shows specific gene expression patterns that indicate its receptivity.